BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 463954)

  • 21. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
    Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
    J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle.
    Odell WD; Griffin J
    J Clin Endocrinol Metab; 1989 Sep; 69(3):528-32. PubMed ID: 2760168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of gonadotropin during the second half of the cycle in women using intrauterine contraception.
    Beling CG; Cederqvist LL; Fuchs F
    Am J Obstet Gynecol; 1976 Jul; 125(6):855-8. PubMed ID: 937412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
    Marrs RP; Kletzky OA; Howard WF; Mishell DR
    Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause.
    Papapetrou PD; Anagnostopoulos NI
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1187-95. PubMed ID: 3923023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chorionic gonadotropin in women fitted with intrauterine device.
    Yarkoni S; Zer TA; Schenker JG
    Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH; Sy L; Cannon W
    Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of specific antisera for radioimmunoassay of human luteinizing hormone (LH) in the presence of human chorionic gonadotropin (hCG).
    Thorell JI; Jeppsson S; Holmström B
    J Clin Endocrinol Metab; 1976 Sep; 43(3):708-11. PubMed ID: 783185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
    Arrata WS; Chatterton RT
    Am J Obstet Gynecol; 1974 Dec; 120(7):954-9. PubMed ID: 4429112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
    Abuzeid MI; Yeoman R; Aksel S
    Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) and human chorionic gonadotropin (beta-hCG) in women using an intrauterine device.
    Tamsen L; Eneroth P
    Contraception; 1986 May; 33(5):497-501. PubMed ID: 2428559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactive relaxin in human serum during the menstrual cycle.
    Bryant GD; Panter ME; Stelmasiak T
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1065-9. PubMed ID: 1206093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intra-uterine contraceptive device--contraceptive or abortifacient?
    Kort H; van der Walt LA
    S Afr Med J; 1978 May; 53(21):864-6. PubMed ID: 358422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteinizing hormone in cervical mucus.
    Moreno-Escallon B; Chappel S; Blasco L
    Fertil Steril; 1982 Apr; 37(4):536-41. PubMed ID: 7067848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma LH-HCG, 17 -estradiol, estrone and progesterone monitoring around ovulation and subsequent nidation.
    Thomas K; De Hertogh R; Pizarro M; Van Exter C; Ferin J
    Int J Fertil; 1973; 18(2):65-73. PubMed ID: 4353919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.